nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Thiotepa—sarcoma	0.156	0.404	CbGbCtD
Bisoprolol—CYP3A4—Mitoxantrone—sarcoma	0.067	0.174	CbGbCtD
Bisoprolol—CYP3A4—Vincristine—sarcoma	0.0461	0.12	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—sarcoma	0.0453	0.118	CbGbCtD
Bisoprolol—CYP3A4—Etoposide—sarcoma	0.0422	0.11	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—sarcoma	0.0288	0.0748	CbGbCtD
Bisoprolol—Breast disorder—Epirubicin—sarcoma	0.000868	0.00141	CcSEcCtD
Bisoprolol—Pain—Mitoxantrone—sarcoma	0.000866	0.00141	CcSEcCtD
Bisoprolol—Constipation—Mitoxantrone—sarcoma	0.000866	0.00141	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000865	0.00141	CcSEcCtD
Bisoprolol—Hypersensitivity—Thiotepa—sarcoma	0.000864	0.00141	CcSEcCtD
Bisoprolol—Hypersensitivity—Dactinomycin—sarcoma	0.000858	0.0014	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Vincristine—sarcoma	0.000851	0.00138	CcSEcCtD
Bisoprolol—Gastritis—Epirubicin—sarcoma	0.000851	0.00138	CcSEcCtD
Bisoprolol—Confusional state—Etoposide—sarcoma	0.00085	0.00138	CcSEcCtD
Bisoprolol—Muscular weakness—Epirubicin—sarcoma	0.000848	0.00138	CcSEcCtD
Bisoprolol—Cardiac arrest—Doxorubicin—sarcoma	0.000846	0.00138	CcSEcCtD
Bisoprolol—Mood swings—Doxorubicin—sarcoma	0.000842	0.00137	CcSEcCtD
Bisoprolol—Asthenia—Thiotepa—sarcoma	0.000842	0.00137	CcSEcCtD
Bisoprolol—Infection—Etoposide—sarcoma	0.000837	0.00136	CcSEcCtD
Bisoprolol—Asthenia—Dactinomycin—sarcoma	0.000835	0.00136	CcSEcCtD
Bisoprolol—Feeling abnormal—Mitoxantrone—sarcoma	0.000835	0.00136	CcSEcCtD
Bisoprolol—Asthma—Epirubicin—sarcoma	0.000831	0.00135	CcSEcCtD
Bisoprolol—Pruritus—Thiotepa—sarcoma	0.00083	0.00135	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000828	0.00135	CcSEcCtD
Bisoprolol—Thrombocytopenia—Etoposide—sarcoma	0.000825	0.00134	CcSEcCtD
Bisoprolol—Tachycardia—Etoposide—sarcoma	0.000822	0.00134	CcSEcCtD
Bisoprolol—Abdominal pain—Vincristine—sarcoma	0.000822	0.00134	CcSEcCtD
Bisoprolol—Body temperature increased—Vincristine—sarcoma	0.000822	0.00134	CcSEcCtD
Bisoprolol—Skin disorder—Etoposide—sarcoma	0.000818	0.00133	CcSEcCtD
Bisoprolol—Hyperhidrosis—Etoposide—sarcoma	0.000815	0.00132	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—sarcoma	0.000812	0.00132	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—sarcoma	0.000812	0.00132	CcSEcCtD
Bisoprolol—Urticaria—Mitoxantrone—sarcoma	0.000805	0.00131	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—sarcoma	0.000804	0.00131	CcSEcCtD
Bisoprolol—Diarrhoea—Thiotepa—sarcoma	0.000803	0.00131	CcSEcCtD
Bisoprolol—Abdominal pain—Mitoxantrone—sarcoma	0.000801	0.0013	CcSEcCtD
Bisoprolol—Body temperature increased—Mitoxantrone—sarcoma	0.000801	0.0013	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000801	0.0013	CcSEcCtD
Bisoprolol—Bronchitis—Epirubicin—sarcoma	0.000799	0.0013	CcSEcCtD
Bisoprolol—Diarrhoea—Dactinomycin—sarcoma	0.000797	0.0013	CcSEcCtD
Bisoprolol—Hypotension—Etoposide—sarcoma	0.000787	0.00128	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—sarcoma	0.000787	0.00128	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—sarcoma	0.000784	0.00128	CcSEcCtD
Bisoprolol—Dizziness—Thiotepa—sarcoma	0.000776	0.00126	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—sarcoma	0.000769	0.00125	CcSEcCtD
Bisoprolol—Hypersensitivity—Vincristine—sarcoma	0.000766	0.00125	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Epirubicin—sarcoma	0.000758	0.00123	CcSEcCtD
Bisoprolol—Paraesthesia—Etoposide—sarcoma	0.000757	0.00123	CcSEcCtD
Bisoprolol—Weight increased—Epirubicin—sarcoma	0.000756	0.00123	CcSEcCtD
Bisoprolol—Dyspnoea—Etoposide—sarcoma	0.000751	0.00122	CcSEcCtD
Bisoprolol—Somnolence—Etoposide—sarcoma	0.000749	0.00122	CcSEcCtD
Bisoprolol—Hypersensitivity—Mitoxantrone—sarcoma	0.000746	0.00121	CcSEcCtD
Bisoprolol—Asthenia—Vincristine—sarcoma	0.000746	0.00121	CcSEcCtD
Bisoprolol—Vomiting—Thiotepa—sarcoma	0.000746	0.00121	CcSEcCtD
Bisoprolol—Pneumonia—Epirubicin—sarcoma	0.000745	0.00121	CcSEcCtD
Bisoprolol—Drowsiness—Epirubicin—sarcoma	0.000741	0.0012	CcSEcCtD
Bisoprolol—Vomiting—Dactinomycin—sarcoma	0.00074	0.0012	CcSEcCtD
Bisoprolol—Rash—Thiotepa—sarcoma	0.00074	0.0012	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—sarcoma	0.000739	0.0012	CcSEcCtD
Bisoprolol—Dermatitis—Thiotepa—sarcoma	0.000739	0.0012	CcSEcCtD
Bisoprolol—Headache—Thiotepa—sarcoma	0.000735	0.0012	CcSEcCtD
Bisoprolol—Rash—Dactinomycin—sarcoma	0.000734	0.00119	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Etoposide—sarcoma	0.000727	0.00118	CcSEcCtD
Bisoprolol—Asthenia—Mitoxantrone—sarcoma	0.000727	0.00118	CcSEcCtD
Bisoprolol—Fatigue—Etoposide—sarcoma	0.000727	0.00118	CcSEcCtD
Bisoprolol—Pain—Etoposide—sarcoma	0.000721	0.00117	CcSEcCtD
Bisoprolol—Constipation—Etoposide—sarcoma	0.000721	0.00117	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—sarcoma	0.00072	0.00117	CcSEcCtD
Bisoprolol—Conjunctivitis—Epirubicin—sarcoma	0.00072	0.00117	CcSEcCtD
Bisoprolol—Diarrhoea—Vincristine—sarcoma	0.000712	0.00116	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—sarcoma	0.00071	0.00115	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—sarcoma	0.000702	0.00114	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—sarcoma	0.0007	0.00114	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—sarcoma	0.000699	0.00114	CcSEcCtD
Bisoprolol—Nausea—Thiotepa—sarcoma	0.000697	0.00113	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—sarcoma	0.000695	0.00113	CcSEcCtD
Bisoprolol—Feeling abnormal—Etoposide—sarcoma	0.000694	0.00113	CcSEcCtD
Bisoprolol—Diarrhoea—Mitoxantrone—sarcoma	0.000693	0.00113	CcSEcCtD
Bisoprolol—Nausea—Dactinomycin—sarcoma	0.000692	0.00112	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—sarcoma	0.000691	0.00112	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—sarcoma	0.000689	0.00112	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Etoposide—sarcoma	0.000689	0.00112	CcSEcCtD
Bisoprolol—Dizziness—Vincristine—sarcoma	0.000688	0.00112	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—sarcoma	0.000685	0.00111	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—sarcoma	0.000677	0.0011	CcSEcCtD
Bisoprolol—Urticaria—Etoposide—sarcoma	0.000669	0.00109	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—sarcoma	0.000667	0.00108	CcSEcCtD
Bisoprolol—Body temperature increased—Etoposide—sarcoma	0.000666	0.00108	CcSEcCtD
Bisoprolol—Abdominal pain—Etoposide—sarcoma	0.000666	0.00108	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—sarcoma	0.000666	0.00108	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—sarcoma	0.000666	0.00108	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—sarcoma	0.000665	0.00108	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—sarcoma	0.000662	0.00108	CcSEcCtD
Bisoprolol—Vomiting—Vincristine—sarcoma	0.000661	0.00108	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—sarcoma	0.00066	0.00107	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—sarcoma	0.000657	0.00107	CcSEcCtD
Bisoprolol—Rash—Vincristine—sarcoma	0.000656	0.00107	CcSEcCtD
Bisoprolol—Dermatitis—Vincristine—sarcoma	0.000655	0.00107	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—sarcoma	0.000655	0.00107	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—sarcoma	0.000653	0.00106	CcSEcCtD
Bisoprolol—Headache—Vincristine—sarcoma	0.000652	0.00106	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—sarcoma	0.000648	0.00105	CcSEcCtD
Bisoprolol—Vomiting—Mitoxantrone—sarcoma	0.000644	0.00105	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—sarcoma	0.000643	0.00105	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—sarcoma	0.000641	0.00104	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—sarcoma	0.00064	0.00104	CcSEcCtD
Bisoprolol—Rash—Mitoxantrone—sarcoma	0.000639	0.00104	CcSEcCtD
Bisoprolol—Dermatitis—Mitoxantrone—sarcoma	0.000638	0.00104	CcSEcCtD
Bisoprolol—Headache—Mitoxantrone—sarcoma	0.000635	0.00103	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—sarcoma	0.000626	0.00102	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—sarcoma	0.000621	0.00101	CcSEcCtD
Bisoprolol—Hypersensitivity—Etoposide—sarcoma	0.000621	0.00101	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—sarcoma	0.00062	0.00101	CcSEcCtD
Bisoprolol—Nausea—Vincristine—sarcoma	0.000618	0.001	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—sarcoma	0.000617	0.001	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—sarcoma	0.000617	0.001	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—sarcoma	0.000617	0.001	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—sarcoma	0.000615	0.001	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—sarcoma	0.000612	0.000996	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—sarcoma	0.000611	0.000993	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—sarcoma	0.000606	0.000986	CcSEcCtD
Bisoprolol—Asthenia—Etoposide—sarcoma	0.000605	0.000983	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—sarcoma	0.000605	0.000983	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—sarcoma	0.000603	0.000981	CcSEcCtD
Bisoprolol—Nausea—Mitoxantrone—sarcoma	0.000602	0.000979	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—sarcoma	0.000599	0.000975	CcSEcCtD
Bisoprolol—Pruritus—Etoposide—sarcoma	0.000596	0.00097	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—sarcoma	0.000594	0.000966	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—sarcoma	0.000593	0.000964	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—sarcoma	0.000588	0.000956	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—sarcoma	0.000582	0.000947	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—sarcoma	0.000579	0.000941	CcSEcCtD
Bisoprolol—Diarrhoea—Etoposide—sarcoma	0.000577	0.000938	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—sarcoma	0.000575	0.000935	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—sarcoma	0.000574	0.000933	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—sarcoma	0.000571	0.000929	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—sarcoma	0.000571	0.000929	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—sarcoma	0.000567	0.000922	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—sarcoma	0.00056	0.000911	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—sarcoma	0.000558	0.000908	CcSEcCtD
Bisoprolol—Dizziness—Etoposide—sarcoma	0.000557	0.000906	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—sarcoma	0.000556	0.000905	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—sarcoma	0.000554	0.000902	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—sarcoma	0.00055	0.000894	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—sarcoma	0.000544	0.000884	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—sarcoma	0.000539	0.000877	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—sarcoma	0.000537	0.000873	CcSEcCtD
Bisoprolol—Vomiting—Etoposide—sarcoma	0.000536	0.000871	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—sarcoma	0.000536	0.000871	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—sarcoma	0.000532	0.000865	CcSEcCtD
Bisoprolol—Rash—Etoposide—sarcoma	0.000531	0.000864	CcSEcCtD
Bisoprolol—Dermatitis—Etoposide—sarcoma	0.000531	0.000863	CcSEcCtD
Bisoprolol—Headache—Etoposide—sarcoma	0.000528	0.000859	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—sarcoma	0.000524	0.000853	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—sarcoma	0.000522	0.000849	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—sarcoma	0.00052	0.000846	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—sarcoma	0.000519	0.000844	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—sarcoma	0.000518	0.000843	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—sarcoma	0.000515	0.000837	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—sarcoma	0.000511	0.000832	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—sarcoma	0.000509	0.000827	CcSEcCtD
Bisoprolol—Cough—Epirubicin—sarcoma	0.000505	0.000821	CcSEcCtD
Bisoprolol—Nausea—Etoposide—sarcoma	0.000501	0.000814	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—sarcoma	0.000497	0.000808	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—sarcoma	0.000493	0.000801	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—sarcoma	0.000493	0.000801	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—sarcoma	0.000493	0.000801	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—sarcoma	0.000492	0.0008	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—sarcoma	0.000491	0.000799	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000489	0.000796	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—sarcoma	0.000487	0.000792	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—sarcoma	0.000483	0.000785	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—sarcoma	0.000482	0.000784	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—sarcoma	0.000481	0.000783	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—sarcoma	0.00048	0.000781	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—sarcoma	0.000476	0.000775	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—sarcoma	0.000473	0.00077	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—sarcoma	0.000472	0.000768	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—sarcoma	0.000471	0.000766	CcSEcCtD
Bisoprolol—Infection—Epirubicin—sarcoma	0.000469	0.000763	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—sarcoma	0.000467	0.00076	CcSEcCtD
Bisoprolol—Shock—Epirubicin—sarcoma	0.000465	0.000756	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—sarcoma	0.000463	0.000753	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—sarcoma	0.000462	0.000752	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—sarcoma	0.000461	0.00075	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—sarcoma	0.000459	0.000746	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—sarcoma	0.000457	0.000743	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—sarcoma	0.000456	0.000742	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—sarcoma	0.000456	0.000742	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—sarcoma	0.000456	0.000742	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—sarcoma	0.000454	0.000739	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000453	0.000736	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—sarcoma	0.00045	0.000733	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—sarcoma	0.000446	0.000725	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—sarcoma	0.000441	0.000718	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—sarcoma	0.000441	0.000717	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—sarcoma	0.000437	0.000711	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—sarcoma	0.000434	0.000706	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00043	0.0007	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—sarcoma	0.00043	0.000699	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—sarcoma	0.000429	0.000697	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—sarcoma	0.000428	0.000696	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—sarcoma	0.000427	0.000695	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—sarcoma	0.000427	0.000694	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—sarcoma	0.000425	0.00069	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—sarcoma	0.000424	0.00069	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—sarcoma	0.000423	0.000687	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—sarcoma	0.000421	0.000685	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—sarcoma	0.00042	0.000683	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—sarcoma	0.000416	0.000676	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—sarcoma	0.000408	0.000664	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000408	0.000663	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—sarcoma	0.000407	0.000662	CcSEcCtD
Bisoprolol—Pain—Epirubicin—sarcoma	0.000404	0.000657	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—sarcoma	0.000404	0.000657	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000398	0.000648	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—sarcoma	0.000395	0.000643	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—sarcoma	0.000392	0.000638	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—sarcoma	0.00039	0.000634	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—sarcoma	0.000389	0.000633	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—sarcoma	0.000389	0.000632	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—sarcoma	0.000386	0.000628	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—sarcoma	0.000385	0.000626	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000377	0.000614	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—sarcoma	0.000377	0.000613	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—sarcoma	0.000375	0.00061	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—sarcoma	0.000374	0.000608	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—sarcoma	0.000374	0.000608	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—sarcoma	0.000373	0.000607	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—sarcoma	0.000373	0.000607	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—sarcoma	0.00036	0.000586	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000357	0.000581	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—sarcoma	0.000348	0.000566	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—sarcoma	0.000347	0.000565	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—sarcoma	0.000346	0.000562	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—sarcoma	0.000346	0.000562	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—sarcoma	0.000339	0.000551	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—sarcoma	0.000334	0.000544	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—sarcoma	0.000323	0.000526	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—sarcoma	0.000322	0.000524	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—sarcoma	0.000314	0.00051	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—sarcoma	0.000312	0.000508	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—sarcoma	0.000309	0.000503	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—sarcoma	0.0003	0.000488	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—sarcoma	0.000299	0.000486	CcSEcCtD
Bisoprolol—Rash—Epirubicin—sarcoma	0.000298	0.000484	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—sarcoma	0.000298	0.000484	CcSEcCtD
Bisoprolol—Headache—Epirubicin—sarcoma	0.000296	0.000481	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—sarcoma	0.000289	0.00047	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—sarcoma	0.000281	0.000456	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—sarcoma	0.000278	0.000452	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—sarcoma	0.000276	0.000448	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—sarcoma	0.000275	0.000448	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—sarcoma	0.000274	0.000445	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—sarcoma	0.00026	0.000422	CcSEcCtD
